ICU Medical Inc. (ICUI) exhibits 36.8% gross margins and 1.0% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 46.6x enterprise multiple and 4.8% implied options volatility.
Sustained 36.8% gross profitability converts into 1.9% operating margin and 1.0% ROIC, outpacing sector cost of capital.
ROIC: 1.0% // GM: 36.8%YoY revenue trajectory of -6.3% paired with 2.18% free cash flow yield supports self-funded R&D and capital return.
REV YOY: -6.3% // FCF YLD: 2.18%Altman Z-Score of 3.80 and Piotroski F-Score of 8/9 indicate low near-term refinancing stress.
ALTMAN Z: 3.80 // F-SCORE: 8/9Trading at 24.0x trailing P/E (— Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.0x // EV/EBITDA: 46.6xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $168.65 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend 0.0% net margins.
NET MARGIN: 0.0% // D/E: 0.60x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for ICUI & activate live FRED threshold breach alerts.